>>> US Research Calls

Research Calls I
  • Upgrades:
    • BP (BP) upgraded to Overweight from Neutral at JPMorgan
    • Editas Medicine (EDIT) upgraded to Buy from Neutral at Guggenheim, tgt $5
    • Graphic Packaging (GPK) upgraded to Overweight from Neutral at JPMorgan, tgt $11.50
    • Lakefront (LKFT) upgraded to Outperform from Sector Perform at RBC Capital, tgt $45
    • Microsoft (MSFT) upgraded to Buy from Hold at Stifel, tgt $575
    • RXO (RXO) upgraded to Neutral from Negative at Susquehanna, tgt $19
  • Downgrades:
    • Accelerant (ARX) downgraded to Underperform from Market Perform at Raymond James
    • Autoliv (ALV) downgraded to Peer Perform from Outperform at Wolfe Research
    • CBIZ (CBZ) downgraded to Market Perform from Outperform at William Blair
    • Compass Therapeutics (CMPX) downgraded to Neutral from Outperform at Wedbush, tgt $1
    • Dauch (DCH) downgraded to Hold from Buy at Jefferies, tgt $7.10
    • PG&E (PCG) downgraded to Neutral from Buy at UBS, tgt $14
    • TotalEnergies (TTE) downgraded to Neutral from Overweight at JPMorgan
  • Others:
    • Aevex (AVEX) resumed with a Buy at Jefferies, tgt $26
    • Amneal Pharmaceuticals (AMRX) initiated with an Outperform at Oppenheimer, tgt $27
    • Amphenol (APH) initiated with an Outperform at Bernstein, tgt $99
    • ANI Pharmaceuticals (ANIP) initiated with a Perform at Oppenheimer, tgt $85
    • Ardent Health (ARDT) initiated with a Market Perform at BMO Capital, tgt $11
    • Belden (BDC) initiated with a Buy at Needham, tgt $140
    • Beta Bionics (BBNX) initiated with an Overweight at Wells Fargo, tgt $28
    • Collegium Pharmaceutical (COLL) initiated with an Outperform at Oppenheimer, tgt $50
    • Community Health (CYH) initiated with a Market Perform at BMO Capital, tgt $3
    • CorMedix (CRMD) initiated with an Outperform at Oppenheimer, tgt $15
    • CoreWeave (CRWV) initiated with a Buy at UBS, tgt $120
    • Enhanced Group (ENHA) initiated with an Overweight at Cantor Fitzgerald, tgt $4
    • Guardian Pharmacy (GRDN) initiated with an Overweight at KeyBanc, tgt $52
    • HCA Healthcare (HCA) initiated with an Outperform at BMO Capital, tgt $495
    • HubSpot (HUBS) initiated with a Sector Perform at FBN Securities, tgt $230
    • Innoviva (INVA) assumed with an Outperform at Oppenheimer, tgt $35
    • Marvell (MRVL) initiated with a Buy at Seaport Research, tgt $270
    • onsemi (ON) initiated with a Buy at Seaport Research, tgt $100
    • ORIC Pharmaceuticals (ORIC) initiated with a Buy at BTIG, tgt $26
    • Pacira (PCRX) initiated with an Outperform at Oppenheimer, tgt $32
    • Porch Group (PRCH) initiated with a Buy at Texas Capital, tgt $20
    • Pulse Biosciences (PLSE) initiated with a Buy at BTIG, tgt $70
    • Semtech (SMTC) initiated with a Buy at Seaport Research, tgt $200
    • SiTime (SITM) initiated with a Neutral at Seaport Research
    • TE Connectivity (TEL) initiated with an Outperform at Bernstein, tgt $243
    • Tenet Healthcare (THC) initiated with a Market Perform at BMO Capital, tgt $265
    • Teva (TEVA) initiated with an Outperform at Oppenheimer, tgt $50
    • Toro Company (TTC) initiated with an Outperform at Oppenheimer, tgt $120
    • Vanda Pharmaceuticals (VNDA) initiated with an Outperform at Oppenheimer, tgt $10
    • Viatris (VTRS) initiated with an Outperform at Oppenheimer, tgt $25